Additional strategies to counteract TNF, such as the administration of low-molecular-weight TNF inhibitors or the introduction of TNF-silencing siRNA, have demonstrated considerable efficacy in mitigating the inflammatory effects associated with AD. This evidence concerns the gene TNF and Alzheimer disease.